India’s Cipla gets regulator nod to import Moderna’s COVID-19 vaccine – CNBC-TV18

(Reuters) – India’s Cipla Ltd has received approval from the country’s drugs regulator to import the COVID-19 vaccine developed by Moderna Inc for restricted emergency use, CNBC-TV18 reported on Tuesday.

(Reporting by Mrinalika Roy in Bengaluru; Editing by Arun Koyyur)

Trump invokes religious rhetoric in praise of Iran rescue, drawing criticism

2h ago

Oil prices open higher as US-Israeli war with Iran continues to disrupt supply

2h ago

Three Gulf funds agree to back Paramount's $81 billion takeover of Warner, WSJ reports

1h ago

Russia says it downed 148 Ukrainian drones in three hours

2h ago

WTA roundup: Jessica Pegula sails to second straight Charleston title

2h ago

How a perilous US rescue mission in Iran nearly went off course

4h ago

Flashback Weekend

12:00 AM - 12:00 AM

Now Playing

93.3 The Drive

Loading Songs

No feed items available at this time.

Pause Auto-Update | Back to Top

No feed items available at this time.

Pause Auto-Update | Back to Top

India’s Cipla gets regulator nod to import Moderna’s COVID-19 vaccine – CNBC-TV18

Current Weather »

Peoria, IL

The Drive on FB

The Drive on Instagram